CymitQuimica logo

CAS 253168-94-4

:

Apremilast intermediate

Description:
Apremilast intermediate, identified by the CAS number 253168-94-4, is a chemical compound that serves as a precursor in the synthesis of apremilast, a medication used primarily for the treatment of psoriatic arthritis and plaque psoriasis. This intermediate typically exhibits characteristics common to organic compounds, including a specific molecular structure that facilitates its role in chemical reactions. It may possess functional groups that influence its reactivity, solubility, and stability. The compound is likely to be a solid at room temperature, with properties that allow it to be handled in a laboratory setting. Its synthesis involves various organic reactions, which may include steps such as condensation, reduction, or substitution. Safety data sheets would provide essential information regarding its handling, storage, and potential hazards, emphasizing the importance of proper laboratory practices. Overall, the characteristics of apremilast intermediate are crucial for its effective use in pharmaceutical applications, contributing to the overall efficacy of the final drug product.
Synonyms:
  • 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)Ethanamine
  • 3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)methyl]-benzenemethanamine
  • Apremilast Intermediate I
  • (s)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(tetrahydrofuran-3-yloxy)quinazolin-4-amine
  • 3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)  methyl]-benzeneme  thanamine
  • 1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethylamine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.